Literature DB >> 23459484

Real-time microscopic observation of Candida biofilm development and effects due to micafungin and fluconazole.

Yukihiro Kaneko1, Susumu Miyagawa, On Takeda, Masateru Hakariya, Satoru Matsumoto, Hideaki Ohno, Yoshitsugu Miyazaki.   

Abstract

To understand the process of Candida biofilm development and the effects of antifungal agents on biofilms, we analyzed real-time data comprising time-lapse images taken at times separated by brief intervals. The growth rate was calculated by measuring the change of biofilm thickness every hour. For the antifungal study, 5-h-old biofilms of Candida albicans were treated with either micafungin (MCFG) or fluconazole (FLCZ). MCFG began to suppress biofilm growth a few minutes after the initiation of the treatment, and this effect was maintained over the course of the observation period. In contrast, the suppressive effects of FLCZ on biofilm growth took longer to manifest: biofilms grew in the first 5 h after treatment, and then their growth was suppressed over the next 10 h, finally producing results similar to those observed with MCFG. MCFG was also involved in the disruption of cells in the biofilms, releasing string-like structures (undefined extracellular component) from the burst hyphae. Thus, MCFG inhibited the detachment of yeast cell clusters from the tips of hyphae. In contrast, FLCZ did not disrupt biofilm cells. MCFG also showed fast antifungal activity against Candida parapsilosis biofilms. In conclusion, our results show that inhibition of glucan synthesis due to MCFG contributed not only to fungicidal activity but also to the immediate suppression of biofilm growth, while FLCZ suppressed growth by inhibiting ergosterol synthesis. Therefore, those characteristic differences should be considered when treating clinical biofilm infections.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23459484      PMCID: PMC3632923          DOI: 10.1128/AAC.02290-12

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  17 in total

Review 1.  Candida biofilms: antifungal resistance and emerging therapeutic options.

Authors:  Duncan M Kuhn; Mahmoud A Ghannoum
Journal:  Curr Opin Investig Drugs       Date:  2004-02

2.  Phenotypic differentiation and seeding dispersal in non-mucoid and mucoid Pseudomonas aeruginosa biofilms.

Authors:  B Purevdorj-Gage; W J Costerton; P Stoodley
Journal:  Microbiology       Date:  2005-05       Impact factor: 2.777

3.  Voriconazole inhibits biofilm formation in different species of the genus Candida.

Authors:  A Valentín; E Cantón; J Pemán; J P Martínez
Journal:  J Antimicrob Chemother       Date:  2012-06-25       Impact factor: 5.790

Review 4.  Candida biofilm: a well-designed protected environment.

Authors:  Pranab K Mukherjee; Guangyin Zhou; Ryan Munyon; Mahmoud A Ghannoum
Journal:  Med Mycol       Date:  2005-05       Impact factor: 4.076

Review 5.  How to build a biofilm: a fungal perspective.

Authors:  Jill R Blankenship; Aaron P Mitchell
Journal:  Curr Opin Microbiol       Date:  2006-10-20       Impact factor: 7.934

6.  Standardized method for in vitro antifungal susceptibility testing of Candida albicans biofilms.

Authors:  G Ramage; K Vande Walle; B L Wickes; J L López-Ribot
Journal:  Antimicrob Agents Chemother       Date:  2001-09       Impact factor: 5.191

7.  Quantitative analysis of proliferation and excretion of Bartonella quintana in body lice, Pediculus humanus L.

Authors:  Naomi Seki; Shinji Kasai; Noriko Saito; Osamu Komagata; Minoru Mihara; Toshinori Sasaki; Takashi Tomita; Tsuguo Sasaki; Mutsuo Kobayashi
Journal:  Am J Trop Med Hyg       Date:  2007-09       Impact factor: 2.345

8.  Effect of growth rate on resistance of Candida albicans biofilms to antifungal agents.

Authors:  G S Baillie; L J Douglas
Journal:  Antimicrob Agents Chemother       Date:  1998-08       Impact factor: 5.191

9.  Pharmacokinetics of fosfluconazole and fluconazole following multiple intravenous administration of fosfluconazole in healthy male volunteers.

Authors:  Satoshi Sobue; Keith Tan; Gary Layton; Malcolm Eve; J Brian Sanderson
Journal:  Br J Clin Pharmacol       Date:  2004-07       Impact factor: 4.335

10.  Patients with long-term oral carriage harbor high-persister mutants of Candida albicans.

Authors:  Michael D Lafleur; Qingguo Qi; Kim Lewis
Journal:  Antimicrob Agents Chemother       Date:  2009-10-19       Impact factor: 5.191

View more
  12 in total

Review 1.  Interaction of Candida albicans with host cells: virulence factors, host defense, escape strategies, and the microbiota.

Authors:  Sarah Höfs; Selene Mogavero; Bernhard Hube
Journal:  J Microbiol       Date:  2016-02-27       Impact factor: 3.422

Review 2.  Candida Biofilms: Development, Architecture, and Resistance.

Authors:  Jyotsna Chandra; Pranab K Mukherjee
Journal:  Microbiol Spectr       Date:  2015-08

3.  Effects of farnesol and lyticase on the formation of Candida albicans biofilm.

Authors:  Nadezhda Sachivkina; Ekaterina Lenchenko; Dmitri Blumenkrants; Alfia Ibragimova; Olga Bazarkina
Journal:  Vet World       Date:  2020-06-08

4.  In vitro activity of micafungin against biofilms of Candida albicans, Candida glabrata, and Candida parapsilosis at different stages of maturation.

Authors:  Małgorzata Prażyńska; Tomasz Bogiel; Eugenia Gospodarek-Komkowska
Journal:  Folia Microbiol (Praha)       Date:  2017-10-05       Impact factor: 2.099

5.  CD101, a Novel Echinocandin, Possesses Potent Antibiofilm Activity against Early and Mature Candida albicans Biofilms.

Authors:  Jyotsna Chandra; Mahmoud A Ghannoum
Journal:  Antimicrob Agents Chemother       Date:  2018-01-25       Impact factor: 5.191

6.  Application of 460 nm visible light for the elimination of Candida albicans in vitro and in vivo.

Authors:  Chuan Wang; Zhiyin Yang; Yinbo Peng; Yuanyuan Guo; Min Yao; Jiying Dong
Journal:  Mol Med Rep       Date:  2018-06-20       Impact factor: 2.952

7.  Association of different Candida species with catheter-related candidemia, and the potential antifungal treatments against their adhesion properties and biofilm-forming capabilities.

Authors:  Xiao-Shu Zuo; Yanan Liu; Xuan Cai; Liying Zhan; Ke Hu
Journal:  J Clin Lab Anal       Date:  2021-02-19       Impact factor: 2.352

Review 8.  Recent insights into Candida albicans biofilm resistance mechanisms.

Authors:  Lotte Mathé; Patrick Van Dijck
Journal:  Curr Genet       Date:  2013-08-25       Impact factor: 3.886

Review 9.  The Role of Antifungals against Candida Biofilm in Catheter-Related Candidemia.

Authors:  Emilio Bouza; Jesús Guinea; María Guembe
Journal:  Antibiotics (Basel)       Date:  2014-12-25

10.  Antifungal Activity of the Natural Coumarin Scopoletin Against Planktonic Cells and Biofilms From a Multidrug-Resistant Candida tropicalis Strain.

Authors:  Ari S O Lemos; Jônatas R Florêncio; Nícolas C C Pinto; Lara M Campos; Thiago P Silva; Richard M Grazul; Priscila F Pinto; Guilherme D Tavares; Elita Scio; Ana Carolina M Apolônio; Rossana C N Melo; Rodrigo L Fabri
Journal:  Front Microbiol       Date:  2020-07-07       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.